Escalon Medical Corp.: 10-Q filed 2015-11-16

Name: Escalon Medical Corp.: 10-Q filed 2015-11-16
Creator: Escalon Medical Corp.

What Escalon Medical Corp. reported in its quarterly report filed 2015-11-16 (fiscal Q1 2016): 31 published measures, 64 facts as tagged in accession 0000862668-15-000016.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-16
Fiscal period: fiscal Q1 2016
Accession: 0000862668-15-000016 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Escalon Medical Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	6,000,021	USD
At 2015-06-30	6,549,070	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	3,293,505	USD
At 2015-06-30	3,559,125	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	2,706,516	USD
At 2015-06-30	2,989,945	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	1,327,135	USD
At 2015-06-30	1,516,761	USD
At 2014-09-30	1,459,346	USD
At 2010-06-30	2,009,554	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-293,189	USD	92
2014-07-01 to 2014-09-30	-458,959	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-128,162	USD	92
2014-07-01 to 2014-09-30	-541,935	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-61,464	USD	92
2014-07-01 to 2014-09-30	-8,273	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-66,940,659	USD
At 2015-06-30	-66,647,470	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	7,526,430	shares	92
2014-07-01 to 2014-09-30	7,526,430	shares	92

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	7,526,430	shares	92
2014-07-01 to 2014-09-30	7,526,430	shares	92

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.04	USD/shares	92
2014-07-01 to 2014-09-30	-0.06	USD/shares	92

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.04	USD/shares	92
2014-07-01 to 2014-09-30	-0.06	USD/shares	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	105,112	USD
At 2015-06-30	48,013	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-293,209	USD	92
2014-07-01 to 2014-09-30	-440,235	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	5,162,076	USD
At 2015-06-30	5,767,824	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	2,480,959	USD
At 2015-06-30	2,761,694	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	1,001,481	USD
At 2015-06-30	1,044,199	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2015-09-30	125,027	USD
At 2015-06-30	125,027	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2015-09-30	2,800	USD
At 2015-06-30	3,200	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	1,236,703	USD
At 2015-06-30	1,785,928	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-09-30	2,318,400	USD
At 2015-06-30	2,219,615	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	1,266,734	USD	92
2014-07-01 to 2014-09-30	1,379,381	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	359,752	USD	92
2014-07-01 to 2014-09-30	324,277	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	7,526,430	shares
At 2014-06-30	7,526,430	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-09-30	69,639,649	USD
At 2015-06-30	69,629,889	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	1,287,641	USD
At 2015-06-30	1,529,428	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-293,189	USD	92
2014-07-01 to 2014-09-30	-440,196	USD	92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	4,765	USD	92
2014-07-01 to 2014-09-30	3,214	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	20	USD	92
2014-07-01 to 2014-09-30	39	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-549,225	USD	92
2014-07-01 to 2014-09-30	-109,559	USD	92

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	98,785	USD	92
2014-07-01 to 2014-09-30	-65,696	USD	92

Inspect the source

Entity: Escalon Medical Corp. / CIK 0000862668
Captured: 2026-09-20T04:59:43.148Z
SEC response SHA-256: 1553c3790334a15d4c4528d0e1ce16eac37d12130ed9cd66f6b338c07ce2533d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862668.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))